Drug Lobbyists Hear HHS Is Preparing Drug-Price Containment Plan

Brand drug lobbyists are worried by signals that the Obama administration is preparing its own drug-price containment plan. Lobbyists, including one from outside the drug industry who has spoken to government officials, said the administration is researching what it can do without Congress, which would distinguish the plan from those recently circulated by Democratic presidential contenders Hillary Clinton and Sen. Bernie Sanders (I-VT) that require significant, and unlikely, acts of Congress. Despite the long-running rumors of an administration proposal, lobbyists...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.